Femtech Market Report and Forecast 2025-2034
Description
The global femtech market size was valued at USD 28.70 Billion in 2024, driven by the increasing focus of startups on developing improved healthcare for specific concerns among women across the globe. The market size is anticipated to grow at a CAGR of 12.40% during the forecast period of 2025-2034 to achieve a value of USD 92.37 Billion by 2034.
Global Femtech Market Overview
Femtech refers to the category of technologies, tools, and devices that are used to focus on the health of women. It includes software, products, tests, and services, ranging from consumer products and apps to diagnostics and telehealth. Femtech focuses on products that utilise technology in a manner to optimise the health of women, proactively and in case of health concerns.
An increase in the need for digital technology in the healthcare sector is driving the growth of the global femtech market. In the upcoming years, the rising popularity of wearable technology to track and monitor the well-being of patients is anticipated to increase the usage of femtech devices.
According to the femtech market analysis, growing concerns about women's health and wellness are projected to fuel the growth of the market for femtech products over the forecast period. As access to women's care in rural regions increases and the awareness regarding wellness in developing countries improves, the market is expected to witness significant demand.
Increasing measures undertaken by the governments of developing countries to boost the adoption of femtech products is one of the key femtech market trends. Femtech products available in the market address issues with pregnancy, reproduction, chronic illnesses, mental health, and general wellness, among others.
As per femtech market research, an increasing number of start-ups are concentrating on developing easy solutions for women's healthcare by comprehending their unique demands and difficulties, supporting market expansion. With more start-ups entering the market and raising awareness of femtech solutions, modernized and effective services will likely be available to more women all over the world.
Global Femtech Market Trends
Rising Application to Drive the Market Growth
Pregnancy and nursing care applications of femtech are expected to account for a substantial portion of the market as more women become pregnant at later ages and complications related to pregnancy and nursing increase. The rising demand for new and innovative products, including smart breast pumps is expected to drive the femtech market worth.
Also, it is anticipated that rising female awareness of contemporary technologies available that can aid in pregnancy and nursing and healthcare programs of various governments will further fuel the femtech market growth. The need for nursing care is anticipated to increase due to growing knowledge of the benefits of nursing and the rising availability of femtech solutions on digital platforms for easy diagnosis and monitoring. A surge in demand for higher-quality supplies and products used in pregnancy and nursing care is further boosting the femtech market value.
Increasing Fund Raisers
In Jan 2023, Oula, a New York-based maternity clinic focused on pregnancy and childbirth was founded on the belief that improving the experience will lead to better health outcomes and lower costs, raised USD 19.1 million in Series A funding.
The company plans to use the funds to improve its full-service maternity care including prenatal, delivery, and postpartum, as well as to increase the availability of group support and sonography services. This announcement has been at a crucial time, as maternal mortality rates in the United States are rising (especially for Black women), restrictions on reproductive rights are being imposed, and parents are facing a hard time, from a lack of accessible childcare to the absence of paid family leave.
Data in the factsheet curated by the World Health Organization showcase that an estimated 287,000 women died during and after pregnancy and childbirth in 2020. Almost 95% of all maternal deaths occurred in low and lower-middle-income countries in 2020, and most could have been prevented. This data showcases the urgency to bring treatments for women facing difficulties during and after pregnancy. This urgency is significant to realize as it is high time now and with all the advancements going around in the healthcare domain, it is important to make some exclusive changes and improvements in the domain of women's health to bolster the global femtech market growth in the forecast period.
Funding activities as mentioned play an important role in the development of the market as it will enable further advancements of technologies and systems to provide targeted and effective maternity healthcare.
Market Launches Boosting the Demand
In July 2023, award-winning gynecological health startup Daye announced the launch of the world’s first virtual Period Pain Clinic to help women and assigned female at birth (AFAB) individuals identify the root cause of their period pain and gain easy access to diagnostic information to help them manage their symptoms appropriately.
In collaboration with NHS GPs, gynecologists, and chronic pelvic pain specialists, Daye developed a groundbreaking new service called Period Pain Clinic (PPC) to help women comprehend and manage their period discomfort conveniently and affordably. This new service conducts a thorough assessment of a patient's symptoms and offers private consultations with a range of specialists, including sexual health nurses, gynecologists, pelvic pain and fertility specialists, nutritionists, dermatologists, breathwork coaches, acupuncturists, and more.
Professionally trained healthcare professionals are available in the facility to enable a faster diagnosis of the root cause of an individual’s period pain and conditions such as endometriosis, adenomyosis, polycystic ovarian syndrome (PCOS), fibroids, and other conditions associated with chronic pelvic pain. These professionals can also address other symptoms that are connected indirectly and are unmanaged, including infertility, hair loss, obesity, and severe acne.
Such exclusive moves to maintain dignity as well as provide convenience with comfort to patients suffering from severe menstrual discomfort and other related symptoms are anticipated to foster the market growth.
Global Femtech Market Segmentations
The EMR’s report titled “Femtech Market Report and Forecast 2025-2034” offers a detailed analysis of the market based on the following segments:
Market Breakup by Product Type
North America is dominating the market for femtech due to factors such as the rising prevalence of chronic conditions in women, the increase in infertility, and the growing awareness of femtech products and services among women. The market for femtech is expanding in the United States and other nations in the region as a result of the high incidences of cancer among women and the growing prevalence of lifestyle-related illnesses.
The expansion of the market in the North American region will also be aided by the increase in investments by the key players in the region, improved healthcare infrastructure, and rising knowledge of illnesses affecting women. With a sizable women workforce that continues to grow, more women are prioritizing their health and seeking technologies to support positive health, creating a sizable demand on the femtech market map.
In September 2023, a Chicago maternal health start-up Partum Health raised USD 3.1 million in seed round funding to improve maternal health outcomes in the United States. Research has shown that each year thousands of women face traumatic pregnancy, childbirth, and postpartum experiences that are largely preventable. Two factors that significantly contribute to the nation’s current maternal health crisis include the relative undersupply of maternity care providers and a lack of postpartum support. Partum Health aims to address and fulfil these crucial gaps of unmet needs by collaborating with obstetricians and midwives to provide patients with complementary and specialized care. Parum Health is also building a model that combines the convenience of mobile apps, chat, and on-demand care with hands-on support so that families can conveniently receive the care. The increasing focus of femtechs on providing convenient yet advanced healthcare is poised to play a crucial role in the femtech market growth during the forecast growth.
Global Femtech Market: Competitor Landscape
In May 2023, Sera Prognostics Inc., The Pregnancy Company® (NASDAQ: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, announced certain commercial changes and plans to optimize its strategy and commercial structure to highly focus business activities on accelerating test adoption and revenue at significantly reduced operating costs.
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
*Please Note:* The report will take 5 business days to complete, after order confirmation.
Global Femtech Market Overview
Femtech refers to the category of technologies, tools, and devices that are used to focus on the health of women. It includes software, products, tests, and services, ranging from consumer products and apps to diagnostics and telehealth. Femtech focuses on products that utilise technology in a manner to optimise the health of women, proactively and in case of health concerns.
An increase in the need for digital technology in the healthcare sector is driving the growth of the global femtech market. In the upcoming years, the rising popularity of wearable technology to track and monitor the well-being of patients is anticipated to increase the usage of femtech devices.
According to the femtech market analysis, growing concerns about women's health and wellness are projected to fuel the growth of the market for femtech products over the forecast period. As access to women's care in rural regions increases and the awareness regarding wellness in developing countries improves, the market is expected to witness significant demand.
Increasing measures undertaken by the governments of developing countries to boost the adoption of femtech products is one of the key femtech market trends. Femtech products available in the market address issues with pregnancy, reproduction, chronic illnesses, mental health, and general wellness, among others.
As per femtech market research, an increasing number of start-ups are concentrating on developing easy solutions for women's healthcare by comprehending their unique demands and difficulties, supporting market expansion. With more start-ups entering the market and raising awareness of femtech solutions, modernized and effective services will likely be available to more women all over the world.
Global Femtech Market Trends
Rising Application to Drive the Market Growth
Pregnancy and nursing care applications of femtech are expected to account for a substantial portion of the market as more women become pregnant at later ages and complications related to pregnancy and nursing increase. The rising demand for new and innovative products, including smart breast pumps is expected to drive the femtech market worth.
Also, it is anticipated that rising female awareness of contemporary technologies available that can aid in pregnancy and nursing and healthcare programs of various governments will further fuel the femtech market growth. The need for nursing care is anticipated to increase due to growing knowledge of the benefits of nursing and the rising availability of femtech solutions on digital platforms for easy diagnosis and monitoring. A surge in demand for higher-quality supplies and products used in pregnancy and nursing care is further boosting the femtech market value.
Increasing Fund Raisers
In Jan 2023, Oula, a New York-based maternity clinic focused on pregnancy and childbirth was founded on the belief that improving the experience will lead to better health outcomes and lower costs, raised USD 19.1 million in Series A funding.
The company plans to use the funds to improve its full-service maternity care including prenatal, delivery, and postpartum, as well as to increase the availability of group support and sonography services. This announcement has been at a crucial time, as maternal mortality rates in the United States are rising (especially for Black women), restrictions on reproductive rights are being imposed, and parents are facing a hard time, from a lack of accessible childcare to the absence of paid family leave.
Data in the factsheet curated by the World Health Organization showcase that an estimated 287,000 women died during and after pregnancy and childbirth in 2020. Almost 95% of all maternal deaths occurred in low and lower-middle-income countries in 2020, and most could have been prevented. This data showcases the urgency to bring treatments for women facing difficulties during and after pregnancy. This urgency is significant to realize as it is high time now and with all the advancements going around in the healthcare domain, it is important to make some exclusive changes and improvements in the domain of women's health to bolster the global femtech market growth in the forecast period.
Funding activities as mentioned play an important role in the development of the market as it will enable further advancements of technologies and systems to provide targeted and effective maternity healthcare.
Market Launches Boosting the Demand
In July 2023, award-winning gynecological health startup Daye announced the launch of the world’s first virtual Period Pain Clinic to help women and assigned female at birth (AFAB) individuals identify the root cause of their period pain and gain easy access to diagnostic information to help them manage their symptoms appropriately.
In collaboration with NHS GPs, gynecologists, and chronic pelvic pain specialists, Daye developed a groundbreaking new service called Period Pain Clinic (PPC) to help women comprehend and manage their period discomfort conveniently and affordably. This new service conducts a thorough assessment of a patient's symptoms and offers private consultations with a range of specialists, including sexual health nurses, gynecologists, pelvic pain and fertility specialists, nutritionists, dermatologists, breathwork coaches, acupuncturists, and more.
Professionally trained healthcare professionals are available in the facility to enable a faster diagnosis of the root cause of an individual’s period pain and conditions such as endometriosis, adenomyosis, polycystic ovarian syndrome (PCOS), fibroids, and other conditions associated with chronic pelvic pain. These professionals can also address other symptoms that are connected indirectly and are unmanaged, including infertility, hair loss, obesity, and severe acne.
Such exclusive moves to maintain dignity as well as provide convenience with comfort to patients suffering from severe menstrual discomfort and other related symptoms are anticipated to foster the market growth.
Global Femtech Market Segmentations
The EMR’s report titled “Femtech Market Report and Forecast 2025-2034” offers a detailed analysis of the market based on the following segments:
Market Breakup by Product Type
- Diagnostics
- Monitoring
- Therapeutic
- Consumer Products
- General Health and Wellness
- Maternity Care
- Menstrual Health
- Pelvic and Uterine Healthcare
- Cancer and Chronic Disease
- Retail
- Online
- Direct-to-consumer
- Hospitals
- Surgical Centers
- Fertility Clinics
- Diagnostics Centers
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
North America is dominating the market for femtech due to factors such as the rising prevalence of chronic conditions in women, the increase in infertility, and the growing awareness of femtech products and services among women. The market for femtech is expanding in the United States and other nations in the region as a result of the high incidences of cancer among women and the growing prevalence of lifestyle-related illnesses.
The expansion of the market in the North American region will also be aided by the increase in investments by the key players in the region, improved healthcare infrastructure, and rising knowledge of illnesses affecting women. With a sizable women workforce that continues to grow, more women are prioritizing their health and seeking technologies to support positive health, creating a sizable demand on the femtech market map.
In September 2023, a Chicago maternal health start-up Partum Health raised USD 3.1 million in seed round funding to improve maternal health outcomes in the United States. Research has shown that each year thousands of women face traumatic pregnancy, childbirth, and postpartum experiences that are largely preventable. Two factors that significantly contribute to the nation’s current maternal health crisis include the relative undersupply of maternity care providers and a lack of postpartum support. Partum Health aims to address and fulfil these crucial gaps of unmet needs by collaborating with obstetricians and midwives to provide patients with complementary and specialized care. Parum Health is also building a model that combines the convenience of mobile apps, chat, and on-demand care with hands-on support so that families can conveniently receive the care. The increasing focus of femtechs on providing convenient yet advanced healthcare is poised to play a crucial role in the femtech market growth during the forecast growth.
Global Femtech Market: Competitor Landscape
In May 2023, Sera Prognostics Inc., The Pregnancy Company® (NASDAQ: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, announced certain commercial changes and plans to optimize its strategy and commercial structure to highly focus business activities on accelerating test adoption and revenue at significantly reduced operating costs.
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- Flo Health Inc.
- Clue Blowink GmbH
- Glow Inc.
- Natural Cycles USA Corp
- Withings
- Fitbit Inc.
- Chiaro Technology Ltd.
- Joylux Inc.
- Coroflo Ltd.
- HeraMED
- Sera Prognostics
- iSono Health, Inc.
- Maven Clinic Co.
- Ovia Health
- Willow Innovations, Inc.
*Please Note:* The report will take 5 business days to complete, after order confirmation.
Table of Contents
350 Pages
- 1 Preface
- 1.1 Objectives of the Study
- 1.2 Key Assumptions
- 1.3 Report Coverage – Key Segmentation and Scope
- 1.4 Research Methodology
- 2 Executive Summary
- 3 Global Femtech Market Overview
- 3.1 Global Femtech Market Historical Value (2018-2024)
- 3.2 Global Femtech Market Forecast Value (2025-2034)
- 4 Global Femtech Market Landscape*
- 4.1 Global Femtech: Developers Landscape
- 4.1.1 Analysis by Year of Establishment
- 4.1.2 Analysis by Company Size
- 4.1.3 Analysis by Region
- 4.2 Global Femtech: Product Landscape
- 4.2.1 Analysis by Product Type
- 4.2.2 Analysis by Application
- 5 Global Femtech Market Dynamics
- 5.1 Market Drivers and Constraints
- 5.2 SWOT Analysis
- 5.2.1 Strengths
- 5.2.2 Weaknesses
- 5.2.3 Opportunities
- 5.2.4 Threats
- 5.3 Porter’s Five Forces Model
- 5.3.1 Bargaining Power of Suppliers
- 5.3.2 Bargaining Power of Buyers
- 5.3.3 Threat of New Entrants
- 5.3.4 Threat of Substitutes
- 5.3.5 Degree of Rivalry
- 5.4 Key Demand Indicators
- 5.5 Key Price Indicators
- 5.6 Industry Events, Initiatives, and Trends
- 5.7 Value Chain Analysis
- 6 Global Femtech Market Segmentation (218-2034 )
- 6.1 Global Femtech Market (2018-2034) by Product Type
- 6.1.1 Market Overview
- 6.1.2 Diagnostics
- 6.1.3 Monitoring
- 6.1.4 Therapeutic
- 6.1.5 Consumer Products
- 6.2 Global Femtech Market (2018-2034) by Application
- 6.2.1 Market Overview
- 6.2.2 General Health and Wellness
- 6.2.3 Maternity Care
- 6.2.4 Menstrual Health
- 6.2.5 Pelvic and Uterine Healthcare
- 6.2.6 Cancer and Chronic Disease
- 6.3 Global Femtech Market (2018-2034) by Distribution Channel
- 6.3.1 Market Overview
- 6.3.2 Retail
- 6.3.3 Online
- 6.4 Global Femtech Market (2018-2034) by End User
- 6.4.1 Market Overview
- 6.4.2 Direct-to-consumer
- 6.4.3 Hospitals
- 6.4.4 Surgical Centers
- 6.4.5 Fertility Clinics
- 6.4.6 Diagnostics Centers
- 6.5 Global Femtech Market (2018-2034) by Region
- 6.5.1 Market Overview
- 6.5.2 North America
- 6.5.3 Europe
- 6.5.4 Asia Pacific
- 6.5.5 Latin America
- 6.5.6 Middle East and Africa
- 7 North America Femtech Market (218-2034)
- 7.1 North America Femtech Market (2018-2034) by Product Type
- 7.1.1 Market Overview
- 7.1.2 Diagnostics
- 7.1.3 Monitoring
- 7.1.4 Therapeutic
- 7.1.5 Consumer Products
- 7.2 North America Femtech Market (2018-2034) by Application
- 7.2.1 Market Overview
- 7.2.2 General Health and Wellness
- 7.2.3 Maternity Care
- 7.2.4 Menstrual Health
- 7.2.5 Pelvic and Uterine Healthcare
- 7.2.6 Cancer and Chronic Disease
- 7.3 North America Femtech Market (2018-2034) by Country
- 7.3.1 United States of America
- 7.3.2 Canada
- 8 Europe Femtech Market (218-2034)
- 8.1 Europe Femtech Market (2018-2034) by Product Type
- 8.1.1 Market Overview
- 8.1.2 Diagnostics
- 8.1.3 Monitoring
- 8.1.4 Therapeutic
- 8.1.5 Consumer Products
- 8.2 Europe Femtech Market (2018-2034) by Application
- 8.2.1 Market Overview
- 8.2.2 General Health and Wellness
- 8.2.3 Maternity Care
- 8.2.4 Menstrual Health
- 8.2.5 Pelvic and Uterine Healthcare
- 8.2.6 Cancer and Chronic Disease
- 8.3 Europe Femtech Market (2018-2034) by Country
- 8.3.1 United Kingdom
- 8.3.2 Germany
- 8.3.3 France
- 8.3.4 Italy
- 8.3.5 Others
- 9 Asia Pacific Femtech Market (218-2034)
- 9.1 Asia Pacific Femtech Market (2018-2034) by Product Type
- 9.1.1 Market Overview
- 9.1.2 Diagnostics
- 9.1.3 Monitoring
- 9.1.4 Therapeutic
- 9.1.5 Consumer Products
- 9.2 Asia Pacific Femtech Market (2018-2034) by Application
- 9.2.1 Market Overview
- 9.2.2 General Health and Wellness
- 9.2.3 Maternity Care
- 9.2.4 Menstrual Health
- 9.2.5 Pelvic and Uterine Healthcare
- 9.2.6 Cancer and Chronic Disease
- 9.3 Asia Pacific Femtech Market (2018-2034) by Country
- 9.3.1 China
- 9.3.2 Japan
- 9.3.3 India
- 9.3.4 ASEAN
- 9.3.5 Others
- 10 Latin America Femtech Market (218-2034)
- 10.1 Latin America Femtech Market (2018-2034) by Product Type
- 10.1.1 Market Overview
- 10.1.2 Diagnostics
- 10.1.3 Monitoring
- 10.1.4 Therapeutic
- 10.1.5 Consumer Products
- 10.2 Latin America Femtech Market (2018-2034) by Application
- 10.2.1 Market Overview
- 10.2.2 General Health and Wellness
- 10.2.3 Maternity Care
- 10.2.4 Menstrual Health
- 10.2.5 Pelvic and Uterine Healthcare
- 10.2.6 Cancer and Chronic Disease
- 10.3 Latin America Femtech Market (2018-2034) by Country
- 10.3.1 Brazil
- 10.3.2 Argentina
- 10.3.3 Mexico
- 10.3.4 Others
- 11 Middle East and Africa Femtech Market (218-2034)
- 11.1 Middle East and Africa Femtech Market (2018-2034) by Product Type
- 11.1.1 Market Overview
- 11.1.2 Diagnostics
- 11.1.3 Monitoring
- 11.1.4 Therapeutic
- 11.1.5 Consumer Products
- 11.2 Middle East and Africa Femtech Market (2018-2034) by Application
- 11.2.1 Market Overview
- 11.2.2 General Health and Wellness
- 11.2.3 Maternity Care
- 11.2.4 Menstrual Health
- 11.2.5 Pelvic and Uterine Healthcare
- 11.2.6 Cancer and Chronic Disease
- 11.3 Middle East and Africa Femtech Market (2018-2034) by Country
- 11.3.1 Saudi Arabia
- 11.3.2 United Arab Emirates
- 11.3.3 Nigeria
- 11.3.4 South Africa
- 11.3.5 Others
- 12 Regulatory Framework
- 12.1 Regulatory Overview
- 12.1.1 US FDA
- 12.1.2 EU EMA
- 12.1.3 INDIA CDSCO
- 12.1.4 JAPAN PMDA
- 12.1.5 Others
- 13 Patent Analysis
- 13.1 Analysis by Type of Patent
- 13.2 Analysis by Publication Year
- 13.3 Analysis by Issuing Authority
- 13.4 Analysis by Patent Age
- 13.5 Analysis by CPC Analysis
- 13.6 Analysis by Patent Valuation
- 13.7 Analysis by Key Players
- 14 Grants Analysis
- 14.1 Analysis by Year
- 14.2 Analysis by Amount Awarded
- 14.3 Analysis by Issuing Authority
- 14.4 Analysis by Grant Application
- 14.5 Analysis by Funding Institute
- 14.6 Analysis by NIH Departments
- 14.7 Analysis by Recipient Organization
- 15 Funding and Investment Analysis
- 15.1 Analysis by Funding Instances
- 15.2 Analysis by Type of Funding
- 15.3 Analysis by Funding Amount
- 15.4 Analysis by Leading Players
- 15.5 Analysis by Leading Investors
- 15.6 Analysis by Geography
- 16 Partnership and Collaborations Analysis
- 16.1 Analysis by Partnership Instances
- 16.2 Analysis by Type of Partnership
- 16.3 Analysis by Leading Players
- 16.4 Analysis by Geography
- 17 Supplier Landscape
- 17.1 Flo Health Inc.
- 17.1.1 Financial Analysis
- 17.1.2 Product Portfolio
- 17.1.3 Demographic Reach and Achievements
- 17.1.4 Mergers and Acquisitions
- 17.1.5 Certifications
- 17.2 Clue Blowink GmbH
- 17.2.1 Financial Analysis
- 17.2.2 Product Portfolio
- 17.2.3 Demographic Reach and Achievements
- 17.2.4 Mergers and Acquisitions
- 17.2.5 Certifications
- 17.3 Glow Inc.
- 17.3.1 Financial Analysis
- 17.3.2 Product Portfolio
- 17.3.3 Demographic Reach and Achievements
- 17.3.4 Mergers and Acquisitions
- 17.3.5 Certifications
- 17.4 Natural Cycles USA Corp
- 17.4.1 Financial Analysis
- 17.4.2 Product Portfolio
- 17.4.3 Demographic Reach and Achievements
- 17.4.4 Mergers and Acquisitions
- 17.4.5 Certifications
- 17.5 Withings
- 17.5.1 Financial Analysis
- 17.5.2 Product Portfolio
- 17.5.3 Demographic Reach and Achievements
- 17.5.4 Mergers and Acquisitions
- 17.5.5 Certifications
- 17.6 Fitbit Inc.
- 17.6.1 Financial Analysis
- 17.6.2 Product Portfolio
- 17.6.3 Demographic Reach and Achievements
- 17.6.4 Mergers and Acquisitions
- 17.6.5 Certifications
- 17.7 Chiaro Technology Ltd.
- 17.7.1 Financial Analysis
- 17.7.2 Product Portfolio
- 17.7.3 Demographic Reach and Achievements
- 17.7.4 Mergers and Acquisitions
- 17.7.5 Certifications
- 17.8 Joylux Inc.
- 17.8.1 Financial Analysis
- 17.8.2 Product Portfolio
- 17.8.3 Demographic Reach and Achievements
- 17.8.4 Mergers and Acquisitions
- 17.8.5 Certifications
- 17.9 Coroflo Ltd.
- 17.9.1 Financial Analysis
- 17.9.2 Product Portfolio
- 17.9.3 Demographic Reach and Achievements
- 17.9.4 Mergers and Acquisitions
- 17.9.5 Certifications
- 17.10 HeraMED
- 17.10.1 Financial Analysis
- 17.10.2 Product Portfolio
- 17.10.3 Demographic Reach and Achievements
- 17.10.4 Mergers and Acquisitions
- 17.10.5 Certifications
- 17.11 Sera Prognostics
- 17.11.1 Financial Analysis
- 17.11.2 Product Portfolio
- 17.11.3 Demographic Reach and Achievements
- 17.11.4 Mergers and Acquisitions
- 17.11.5 Certifications
- 17.12 iSono Health, Inc.
- 17.12.1 Financial Analysis
- 17.12.2 Product Portfolio
- 17.12.3 Demographic Reach and Achievements
- 17.12.4 Mergers and Acquisitions
- 17.12.5 Certifications
- 17.13 Maven Clinic Co.
- 17.13.1 Financial Analysis
- 17.13.2 Product Portfolio
- 17.13.3 Demographic Reach and Achievements
- 17.13.4 Mergers and Acquisitions
- 17.13.5 Certifications
- 17.14 Ovia Health
- 17.14.1 Financial Analysis
- 17.14.2 Product Portfolio
- 17.14.3 Demographic Reach and Achievements
- 17.14.4 Mergers and Acquisitions
- 17.14.5 Certifications
- 17.15 Willow Innovations, Inc.
- 17.15.1 Financial Analysis
- 17.15.2 Product Portfolio
- 17.15.3 Demographic Reach and Achievements
- 17.15.4 Mergers and Acquisitions
- 17.15.5 Certifications
- 18 Global Femtech Market – Distribution Model (Additional Insights)
- 18.1 Overview
- 18.2 Potential Distributors
- 18.3 Key Parameters for Distribution Partner Assessment
- 19 Key Opinion Leaders (KOL) Insights (Additional Insight)
- 20 Company Competitiveness Analysis (Additional Insight)
- 20.1 Very Small Companies
- 20.2 Small Companies
- 20.3 Mid-Sized Companies
- 20.4 Large Companies
- 20.5 Very Large Companies
- 21 Payment Methods (Additional Insight)
- 21.1 Government Funded
- 21.2 Private Insurance
- 21.3 Out-of-Pocket
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
